Lucence
PrivateLast Round
Series A
Extension
Nov 10, 2023
Total Funding Raised
$74.35M
Company Overview
Lucence is a precision oncology company that develops non-invasive liquid biopsy tests for early cancer detection and treatment selection.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lucence Comparables
Compare Lucence with similar companies based on industry and business-model similarity.
Lucence Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Nov 10, 2023 | ||||
| Series A | Nov 20, 2019 |
Key People
Founding team and executive leadership
Lucence Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Chen Capital Ventures | Series A Extension |
| Heliconia Capital | Series A, Series A Extension |
| SGInnovate | Series A |
| Openspace Capital | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 15, 2025
Grew 18% QoQ, from 83 to 98 employees.
- Jul 1, 2025
Monthly visitors increased 88% MoM, reaching 3,000.
Lucence Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Lucence's valuation, stock price, and market status.